计算溶液所需的质量、体积或浓度。
STAT3-IN-36 (compound 11g) is a triple-target inhibitor targeting LRPPRC , STAT3 , and CDK1 with anticancer activity. STAT3-IN-36 binds to LRPPRC, STAT3 , and CDK1 , exerting a stronger anticancer effect than TMF or Capecitabine. STAT3-IN-36 inhibits HGC27 cells with IC 50 1.8 μM..